1. Introduction {#sec1-ijerph-17-03239}
===============

Quinolone antibiotics (QAs) are a new class of artificially synthesized anti-infective drugs. They are widely used in the treatment of various infectious diseases due to their broad bactericidal spectrum, strong antibacterial properties, low toxicity, few side effects, and low price \[[@B1-ijerph-17-03239]\]. They are a class of antibiotics widely applied in veterinary medicine. After usage, QAs will remain in the animal as their original molecular structures or pass through feces and urine in the form of metabolites. These QAs and their metabolites will excrete into the external environment \[[@B2-ijerph-17-03239]\]. According to Xander et al. \[[@B3-ijerph-17-03239]\], 47 research papers have reported the distribution of QAs in the environment and found that their residues are concentrated worldwide including in Pearl River, Huangpu River, Xiaoqing River, Hai River, Baiyangdian Lake, and Dongting Lake in China; densely populated watersheds such as Lake Ontario in North America, Taft River and in Europe, and Mekong River in Asia. Zhang et al. \[[@B4-ijerph-17-03239]\] used the III fugacity model to study the distribution characteristics of QAs in 58 watersheds in China. The results showed that after metabolism in humans and animals, the total amount of QAs excreted from feces and urine is 5.4 × 10^7^ kg. Only 0.02 × 10^7^ kg are removed in wastewater treatment, while the remaining 5.38 × 10^7^ kg still directly enter the receiving environment. Chen et al. \[[@B5-ijerph-17-03239]\] used gas chromatography and mass spectrometry to detect QA concentrations in 19 key groundwater monitoring wells in Beijing. The average concentrations of the QAs ciprofloxacin and norfloxacin were found to be 4.9 and 0.2 ng, respectively. In addition, studies have shown that the levels of norfloxacin, ciprofloxacin, and enoxacin in groundwater in Spain, were 64.13, 38.93, 44.47 ng, respectively \[[@B6-ijerph-17-03239]\]. Norfloxacin, ciprofloxacin, and enoxacin in the groundwater of a Swedish pharmaceutical company reached 31, 14,000, and 1900 ng, respectively \[[@B7-ijerph-17-03239]\]. These studies have shown that the high residual concentrations of QAs are a threat to the environment. QAs accumulate in various aquatic organisms, however, the concentration of different QAs are quite different. QAs, including ofloxacin (2.72 µg/kg), enrofloxacin (762.34 µg/kg), and ciprofloxacin (3.08 µg/kg) were found in bivalve samples \[[@B8-ijerph-17-03239]\]. A mean value of ofloxacin (5.58 µg/kg), enrofloxacin (3.08 µg/kg), ciprofloxacin (4.17 µg/kg), and norfloxacin (23.8 µg/kg) were found in the muscles of fish, turtles, and birds from Baiyangdian Lake, China \[[@B9-ijerph-17-03239]\]. Li et al. \[[@B10-ijerph-17-03239]\] found that among 22 antibiotics, QAs had the highest concentration in 190 mollusks samples with a mean concentration of 86.76 μg/kg dry weight. The investigation of antibiotics in mollusks from Bohai Sea, China, indicated that the mean concentrations of QAs in the mollusks were in the order of "NOR \> OFL \> CIP \> FLE \> SAR \> LOM \> ENR \> DIF". The bioaccumulation capacity of QAs is highly relevant to their molecular structures \[[@B10-ijerph-17-03239]\]. Therefore, it is of critical importance that the relationship between QAs molecular structures and their characteristics can be identified, so that environmentally friendly QA derivatives can be generated.

3D quantitative structure--activity relationship (3D-QSAR) models have been utilized to design and develop potent drugs by correlating 3D-structural features of the chemicals with properties of interest \[[@B11-ijerph-17-03239]\]. Among the existing 3D-QSAR methods, the Comparative Molecular Field Analysis (CoMFA) and the Comparative Molecular Similarity Indices Analysis (CoMSIA) are extensively used in the current practice of rational drug design \[[@B12-ijerph-17-03239]\]. 3D-QSAR has been applied to design environmentally friendly molecules. Wang et al. \[[@B13-ijerph-17-03239]\] designed a pentachlorophenol molecule with lower bioaccumulation by 3D-QSAR. Tong et al. \[[@B14-ijerph-17-03239]\] studied the design of HIV protease inhibitors by using a certain 3D-QSAR method (CoMFA or CoMSIA). Gu et al. \[[@B15-ijerph-17-03239]\] predicted the octanol-water partition coefficient for polychlorinated naphthalenes through 3D-QSAR models. However, there are still very limited studies about the use of 3D-QSAR to predict the environmentally friendly properties of QAs. Zhao et al. \[[@B16-ijerph-17-03239]\] combined QSAR/QSPR with molecular docking to examine the biodegradability of C20-carbonyl and the C21-carboxyl groups of fluoroquinolones. Zhao et al. \[[@B17-ijerph-17-03239]\] designed new fluoroquinolones using SYBYL-X 2.0. After changing the molecular groups, the photodegradability of new fluoroquinolones increased from 15.04% to 40.92% \[[@B17-ijerph-17-03239]\].

To construct a 3D-QSAR model for QA analysis, effective methods for detection of QAs in environmental samples are needed so as to obtain infrared and ultraviolet spectral characteristics of QAs to build the database. Infrared and ultraviolet spectral based analytical methods have been well developed for QA detection. Claine \[[@B18-ijerph-17-03239]\], Efthimiadou et al. \[[@B19-ijerph-17-03239]\], Skyrianou et al. \[[@B20-ijerph-17-03239]\], and Zampakou et al. \[[@B21-ijerph-17-03239]\] conducted infrared spectroscopy analysis to detect QAs. Bailac et al. \[[@B22-ijerph-17-03239]\] detected quinolones in chicken tissues by liquid chromatography based on ultraviolet spectral analysis. Zampakou et al. \[[@B21-ijerph-17-03239]\] studied the interaction of quinolone antimicrobial complexes with calf-thymus deoxyribonucleic acid investigated by ultraviolet spectroscopy. However, 3D-QSAR model development needs a large amount of infrared and ultraviolet spectral characteristics of QAs as inputs. Obtaining such information is expensive and time-consuming. Rather than using experimental analysis to generate infrared and ultraviolet spectral data, theoretical calculation methods \[[@B23-ijerph-17-03239],[@B24-ijerph-17-03239]\] can assist QAs quantification to speed up the database generation. Among them, the Density Functional Theory (DFT) based calculation has been widely adopted. Qiu \[[@B25-ijerph-17-03239]\] et al. used DFT to calculate the infrared and ultraviolet spectra of phthalate esters and their derivatives, and used 3D-QSAR to analyze the spectral changes of phthalates before and after substitution. Yang \[[@B26-ijerph-17-03239]\] et al. used DFT to calculate the infrared spectra of 36 polybrominated biphenyl molecules and recorded the highest infrared vibration intensity of each molecule.

DFT can help to obtain either infrared or ultraviolet spectra of QAs. These infrared or ultraviolet spectra information can then feed a 3D-QSAR model as a single-factor input. However, instead of using two single-factor inputs (i.e., infrared spectra intensities and ultraviolet spectra intensities), an infrared-ultraviolet integrated-factor is desired to increase the efficiency and accuracy of a 3D-QSAR model. It is thus essential to introduce an effective method for integrating infrared and ultraviolet spectral characteristics accurately. The fuzzy matter-element analysis theory can serve this purpose. It can solve the multiple parameter evaluation problem of incompatibility through establishing the corresponding matter-element \[[@B27-ijerph-17-03239]\]. Yang et al. \[[@B28-ijerph-17-03239]\] used the fuzzy matter-element method to assess the water resources carrying capacity of six regions in Huai River, China. Liu and Zou \[[@B29-ijerph-17-03239]\] used the fuzzy matter-element evaluation method to assess water quality, obtaining very similar results to the official reported water quality. Compared with the traditional method for superscale calculation, the fuzzy matter-element analysis method has lower workload and would overcome the adverse effects from abnormal values. The integration of fuzzy matter-element method and 3D-QSAR models has a great potential for generating more accurate results, though the topic has not been tackled in previous studies.

In this study, 24 QAs were selected to build the 3D-QSAR models, and among them, marbofloxacin and levofloxacin were selected as the target molecules to be modified. DFT was used obtain infrared and ultraviolet spectra intensities of 24 QAs. The fuzzy matter-element method was adopted to deal with the magnitude of single spectrum (infrared spectral intensity (IRI) and ultraviolet spectral intensity (UVI)) intensities, and the combined effect (CI) values that were obtained. In addition, a 3D-QSAR model based on CI was constructed, and the substituted sites of QAs (improving the CI values) were precisely obtained based on the contour map. The associated CI, IRI, and UVI were investigated and compared. Eventually, the stability, functionality (genetic toxicity), and environmental friendliness (bioaccumulation and biodegradability) of all QA derivatives were evaluated in order to generate more environmentally friendly QA derivatives. This study considers both functionality and environmental friendliness of QA derivatives which leads to a tool for a generation of new antibiotics in the future.

2. Materials and Methods {#sec2-ijerph-17-03239}
========================

2.1. Data Sources {#sec2dot1-ijerph-17-03239}
-----------------

The theoretical calculations of the infrared and ultraviolet spectra of the 24 QAs studied in this paper are based on Gaussian-09 software (Gaussian Inc., Wallingford, CT, USA). Gaussian is the most widely used software package for computational and quantum chemistry \[[@B30-ijerph-17-03239]\]. Gaussian can be used to process larger molecular weight structures such as anthraquinone, polyhydroxylated anthroquinones, and polyfluorinated dibenzo-p-dioxins for research and calculation \[[@B24-ijerph-17-03239],[@B31-ijerph-17-03239]\]. DFT is a classical computational method of electronic structure theory which has been frequently used \[[@B31-ijerph-17-03239]\]. In most DFT calculations today, the combination of Gaussian orbits is commonly used to represent atomic orbits \[[@B32-ijerph-17-03239]\]. The infrared spectrum and ultraviolet spectrum are optimized for the structure of QAs in a gaseous environment at the B3LYP/6-311G (d) level. The infrared spectrum is the optimal structure and its value is calculated and corrected by a correction factor of 0.9614. The ultraviolet spectrum is based on the optimized ground-state and excited-state geometry, calculated using the DFT method \[[@B32-ijerph-17-03239]\].

2.2. Calculation of the CI Based on Fuzzy Matter-Element Method {#sec2dot2-ijerph-17-03239}
---------------------------------------------------------------

### 2.2.1. Construction of Composite Fuzzy Matter-Element Matrix about QAs' CI {#sec2dot2dot1-ijerph-17-03239}

The elementary elements of an ordered triad R = (*M*, *C*, *q*) are described by the three matter-elements: quinolones (*M*), detection type (*C*), and spectral intensity (*q*) \[[@B33-ijerph-17-03239]\]. There are two types of detection methods of quinolone *M*: infrared spectrum (*C*~1~) and ultraviolet spectrum (*C*~2~), corresponding spectral intensities *q*~1~*, q*~2~*, ..., q*~24~, and *R* is called m-dimensional fuzzy matter-element. When all the quantities in the composite matter-element (*R~m~*) have ambiguity, then *R~m~* is called a composite fuzzy matter-element and can be recorded as:$$R_{mn} = \begin{bmatrix}
{~M_{1}~} & {M_{2}~\cdots} & M_{24} \\
{C_{1}~q_{11}} & {q_{12}~\cdots} & q_{124} \\
{C_{2~}q_{21}} & {q_{22}~\cdots} & q_{224} \\
\end{bmatrix}$$ where *R~mn~* is m dimensional matter-element for 24 QAs, *C~j~* is the detection type of *j*-th characteristic (*j* = 1, 2), *M~i~* the *i*-th molecule (*i* = 1, 2, ..., 24), *q~ij~* is the *i*-th spectral intensity corresponding to the *j*-th detection type of a molecule.

### 2.2.2. Determination of Subordination Membership Degree of QAs' CI {#sec2dot2dot2-ijerph-17-03239}

The subordination membership degree indicates the fuzzy value corresponding to the single effect parameter of the infrared and ultraviolet spectrums belonging to the standard value of each single effect parameter. The degree of membership is represented by *η~ij~*. The fuzzy matter-element matrix *R'~mn~* of the preferential membership can be written as:$$R^{\prime}{}_{mn} = \begin{bmatrix}
{~M_{1}~} & {M_{2}~\cdots} & M_{24} \\
{C_{1}~\eta_{11}} & {\eta_{12}~\cdots} & \eta_{124} \\
{C_{2~}\eta_{21}} & {\eta_{22}~\cdots} & \eta_{224} \\
\end{bmatrix}$$ where *R'~mn~* is the priority membership fuzzy matter-element; *η~ij~* is the priority membership of the *j*-th detection type of the *i*-th molecule belonging to the standard sample, *i* = 1, 2, ..., 24; *j* = 1, 2. The priority membership can be recorded as:$$\left\{ \begin{matrix}
{\eta_{ij} = \frac{q_{ij}}{{Max}q_{ij}}~({higher}\ {is}\ {the}\ {better})} \\
{\eta_{ij} = \frac{{Min}q_{ij}}{q_{ij}}~({lower}\ {is}\ {the}\ {better})} \\
\end{matrix} \right.$$ where *Maxq~ij~* represents the maximum value of the spectral intensity in each detection type corresponding to each molecule; *Minq~ij~* represents the minimum value of the spectral intensity in each detection type corresponding to each molecule. It is easier to detect the effect of infrared and ultraviolet spectra, when the value of the effects is larger. Therefore, the largest index will be used for further calculation.

### 2.2.3. Determination of Standard Fuzzy Matter-Element and Variance Compound Fuzzy Matter-Element Matrix for the CI of QAs' IRI and UVI {#sec2dot2dot3-ijerph-17-03239}

The m-dimensional standard fuzzy matter-element *R*~0*m*~ is the maximum or minimum value of the spectral strength of the superiority of the spectral intensity in each detection type in the fuzzy matter-of-priority membership. The form is as follows:$$R_{0m} = \begin{bmatrix}
{~M_{0}} \\
{~C_{1}~\eta_{01}} \\
{C_{2}~\eta_{02}} \\
\end{bmatrix}$$ where *M*~0~ represents the standard sample; *η*~0*j*~ represents the maximum value of the membership degree of the *j*-th detection type.

*R~Δ~* of variance compound fuzzy matter element can be written as:$$R_{\Delta} = \begin{bmatrix}
{~M_{1}~} & {M_{2}~\cdots} & M_{24} \\
{C_{1}~\Delta_{11}} & {\Delta_{12}~\cdots} & \Delta_{124} \\
{C_{2~}\Delta_{21}} & {\Delta_{22}~\cdots} & \Delta_{224} \\
\end{bmatrix}$$ where *Δ~ij~*= (*η*~0*j*~-*η~ij~*)^2^; because the largest subordination membership degree of this paper is the most optimum, *η*~0*j*~ equals to 1.

### 2.2.4. Determination of Weighting for Evaluation Index of the CI of QAs' IRI and UVI {#sec2dot2dot4-ijerph-17-03239}

The weight determination methods include a subjective weighting approach and objective weighting approach \[[@B34-ijerph-17-03239]\]. The subjective weighting approach in this paper uses the empirical method and the objective weighting approach uses the entropy method. The entropy method is calculated according to the following steps:

\(1\) Construct a judgment matrix *R* for the infrared spectrum and ultraviolet spectrum of 24 QAs, and normalize *R* to obtain a normalized judgment matrix A. Determine the entropy of the *j*-th detection type according to the definition of entropy:$$S_{j} = \frac{1}{lnn}\left\{ {\sum_{i = 1}^{n}\left\lbrack {\frac{1 + a_{ij}}{\sum_{i = 1}^{n}\left( {1 + a_{ij}} \right)}ln\frac{1 + a_{ij}}{\sum_{i = 1}^{n}\left( {1 + a_{ij}} \right)}} \right\rbrack} \right\}~\left( {i = 1,\ 2,\ \ldots,\ 24;\ j = 1,2} \right)$$ where *S~j~* is the entropy of the *j*-th detection type; *a~ij~* is the fuzzy value of each item in the normalized judgment matrix.

\(2\) Calculate the entropy weighting of each detection type, it can be recorded as follows:$$w_{j} = \frac{1 - S_{j}}{m - \sum_{j = 1}^{m}S_{j}}~{({0 \leq w_{j} \leq 1,~\sum_{j = 1}^{m}w_{j} = 1})}$$ where *w~j~* is the entropy of the *j*-th detection type, *j* = 1, 2.

\(3\) Determine the comprehensive weights of the comprehensive effect parameters of QAs' infrared and ultraviolet spectra:

The objective weighting *w~j~* determined by the entropy method is combined with the subjective weighting *θ~j~* determined by the empirical method. The comprehensive weighting *w'~j~* of each detection type is finally determined as:$$w^{\prime}{}_{j} = \xi\theta_{j} + \left( {1 - \xi} \right)~w_{j}~\left( {j = 1,2} \right)$$ where ξ is the preference coefficient of the subjective weighting ξ∈\[0,1\]. A larger ξ value indicates that the research focuses more on subjective weighting; conversely, a lower ξ indicates that decision makers should pay more attention to objective weighting.

### 2.2.5. Euclidean Closeness Calculation for the CI of QAs' IRI and UVI {#sec2dot2dot5-ijerph-17-03239}

The Euclidean closeness was used to comprehensively analyze the infrared and ultraviolet spectra of 24 QAs. The calculation formula of Euclidean closeness *e~i~* can be determined as follows:$$e_{i} = 1 - \sqrt{\sum_{j = 1}^{m}w^{\prime}{}_{j}\Delta_{ij}}\ \left( {i = 1,\ 2,\ \ldots,24;\ j = 1,2} \right)$$

2.3. Construction of 3D-QSAR Model to Generate Environmentally Friendly QAs {#sec2dot3-ijerph-17-03239}
---------------------------------------------------------------------------

Based on the database generated from [Section 2.2](#sec2dot2-ijerph-17-03239){ref-type="sec"}, a 3D-QSAR model was constructed in this paper. The 3D-QSAR analysis was performed using SYBYL-X2.0 software (Tripos Company, St. Louis, USA) \[[@B35-ijerph-17-03239]\]. The comprehensive effects of infrared and ultraviolet spectra of 24 QAs were calculated based on the fuzzy matter-element method. When calculating the parameters of the CoMFA field, partial least squares (PLS) analysis was used to establish the relationship between the structure of the target compound and the biological activity \[[@B36-ijerph-17-03239]\]. When using PLS analysis, the Leave-One-Out method was used to cross-validate the training set compounds and calculate the cross-validation coefficient *q^2^* and the number of optimal principal components *n* \[[@B37-ijerph-17-03239]\]. Non-cross-validation regression (No Validation) was then used to perform regression analysis and calculate the non-cross-validation coefficient *r^2^*, standard deviation *SEE*, and test value *F*, in order to complete the establishment of the CoMFA model \[[@B38-ijerph-17-03239]\]. In addition, single-effect models of infrared and ultraviolet spectra also follow the above operations to construct CoMFA models of single-effects of infrared and ultraviolet spectra of QAs.

3. Results and Discussion {#sec3-ijerph-17-03239}
=========================

3.1. Calculation of QAs' IRI and UVI based on DFT {#sec3dot1-ijerph-17-03239}
-------------------------------------------------

There are many types of QAs, many of which have different behavioral characteristics and hazards in the environment. Therefore, determining the types of QAs that exist in the environment and extracting spectral information assists prediction and evaluation of the magnitude of the hazards caused by such substances to the environment. In this study, the UVI of 24 QAs were obtained using the DFT method based on the optimized ground-state and excited-state geometry. The IRI of 24 QAs were calculated using the Gaussian 09 software with a correction factor of 0.9614. The intensities of both the infrared and ultraviolet spectrum were optimized in a gaseous environment at the B3LYP/6-311G (d) level. [Table 1](#ijerph-17-03239-t001){ref-type="table"} lists the calculation results of infrared and ultraviolet spectral intensities of 24 QAs.

3.2. Determination of CI of QAs' IRI and UVI Based on Fuzzy Matter-Element Method {#sec3dot2-ijerph-17-03239}
---------------------------------------------------------------------------------

### 3.2.1. Subordination Membership Degree, Standard Fuzzy Matter-Element and Variance Compound Fuzzy Matter-Element Matrix {#sec3dot2dot1-ijerph-17-03239}

Two characteristics of QAs, infrared and ultraviolet spectrums, were applied and the associated fuzzy membership degree, standard fuzzy matter-element and variance composite fuzzy matter-element matrix of the two spectral intensities were calculated using the fuzzy matter-element method according to Equations (1)--(9). The calculation results are summarized in [Table 2](#ijerph-17-03239-t002){ref-type="table"}, which were used to further calculate the CI of QAs.

### 3.2.2. Comprehensive Weightings for CI of QAs' IRI and UVI {#sec3dot2dot2-ijerph-17-03239}

The data of the infrared and ultraviolet spectra of QAs are derived from the results of DFT calculations in quantum chemical calculations. Both detection methods have shown similar physical significance when detecting quinolones \[[@B39-ijerph-17-03239],[@B40-ijerph-17-03239]\]. Therefore, the subjective weighting for both infrared and ultraviolet spectra was set as 0.5. In addition, the obtained data was normalized before calculating the objective weightings. The specific results are shown in [Table 3](#ijerph-17-03239-t003){ref-type="table"}.

### 3.2.3. CI of QAs' IRI and UVI {#sec3dot2dot3-ijerph-17-03239}

In this study, the Euclidean closeness was calculated by using Equation (9) with the processed single-effect parameters of 24 QAs representing the comprehensive effects of infrared and ultraviolet spectra of these QAs. As presented in [Table 4](#ijerph-17-03239-t004){ref-type="table"}, the CI values obtained based on the fuzzy matter-element method varied from 0.1613 to 0.8958. The dynamic range of the CI values is 5.6, greater than that stated in previous studies \[[@B41-ijerph-17-03239],[@B42-ijerph-17-03239],[@B43-ijerph-17-03239],[@B44-ijerph-17-03239],[@B45-ijerph-17-03239]\]. It indicated that the CI data set of QAs' IRI and UVI could be employed to build the associated 3D-QSAR model based on the comprehensive effect.

3.3. Construction and Evaluation of 3D-QSAR Model Based on CI of QAs' IRI and UVI {#sec3dot3-ijerph-17-03239}
---------------------------------------------------------------------------------

### 3.3.1. Construction of the 3D-QSAR Model {#sec3dot3dot1-ijerph-17-03239}

The CI of 16 QAs were randomly selected as data sources. Temafloxacin with the highest CI (*e*~24~ = 0.7296) was chosen as the target molecule, 13 QAs as the training set, and the remaining 4 QAs as the testing set (Temafloxacin exists in both the training set and the testing set). Based on these comprehensive effects, a 3D-QSAR model was constructed. SYBYL-X2.0 (Tripos Company, USA) was used in this study to select the lowest energy conformation of the molecule as the dominant stable conformation, and G-H electrical charges (Gasteiger--Huckel) were loaded. The maximum number of optimizations was 10,000 using the Powell energy gradient method, and the energy convergence was limited to 0.005 kJ/mol \[[@B46-ijerph-17-03239],[@B47-ijerph-17-03239]\]. The optimized molecules were stored in the database for alignment. All molecules were aligned with the pharmacophore characteristic elements in the marked area shown in [Figure 1](#ijerph-17-03239-f001){ref-type="fig"} as the basic skeleton. The structures of selected target molecules, marbofloxacin and levofloxacin are also shown in [Figure 1](#ijerph-17-03239-f001){ref-type="fig"}. The CoMFA module will be used to establish the infrared and ultraviolet spectra suitable for QAs by using the basic skeleton for comprehensive effects prediction.

### 3.3.2. Performance Evaluation of the 3D-QSAR Model {#sec3dot3dot2-ijerph-17-03239}

The evaluation results of 3D-QSAR model show that in the CoMFA model, the cross-validation coefficient *q^2^* is 0.67 (*q^2^* \> 0.5), and the best principal component *n* is 3, indicating that the model has a good prediction ability. The cross-validation coefficient *R^2^* is 0.984 (\>0.9), the standard error of estimate (*SEE*) is 0.023, and the F-test value is 179.271, indicating that the model has a good ability to fit and predict \[[@B48-ijerph-17-03239]\].

Golbraikh and Ropsha \[[@B49-ijerph-17-03239]\] confirmed that the strict QSAR model verification procedures should include internal and external verification. The use of internal verification parameters such as *q^2^* cannot assess the quality of the model. Therefore, external verification methods need to be applied. External verification methods are one of the most valuable verification methods, and were applied to evaluate the predictive ability of the obtained model. The overall predictive ability of the CoMFA model was externally verified by predicting the activity of the compounds in the independent testing set \[[@B49-ijerph-17-03239]\]. The predictive ability of the model is represented by the predicted *r^2^~pred~*, and its calculation formula is as follows:$$r_{pred}^{2} = 1 - \frac{PRESS}{SD}$$

In the formula, *PRESS* refers to the sum of the squared deviations between the calculated and predicted values in the test set, and *SD* refers to the sum of the squared deviations between the calculated values of the compounds in the test set and the average values of the calculated values of the compounds in the training set.

The constructed CoMFA model was used to predict the activity of the test set molecules, and external verification was performed based on the prediction results ([Table 5](#ijerph-17-03239-t005){ref-type="table"}). The results show that the interaction test coefficient *r^2^~pred~* of the external prediction set is 0.9695 (\>0.6) \[[@B50-ijerph-17-03239]\]. Tropsha method was also used to evaluate the external prediction ability of this model. The calculation results indicated that r was 0.9932, r^2^ was 0.9864 (\>0.6), k was 1.0269 (0.85 \< k \< 1.15), k' was 0.9712 (0.85 \< k' \< 1.15), r~0~^2^ was 0.893, and r~0′~^2^ was 0.932. Furthermore, (r^2^−r~0~^2^)/r^2^ = −0.0060 (\<0.1) and (r^2^−r~0′~^2^)/r^2^= 0.0115 (\<0.1) The above parameters all met the external verification requirements \[[@B51-ijerph-17-03239],[@B52-ijerph-17-03239]\], therefore, the constructed 3D-QSAR model has shown a satisfactory external prediction capability.

3.4. Determination of Substitution Characteristics Based on the Contour Maps {#sec3dot4-ijerph-17-03239}
----------------------------------------------------------------------------

In the CoMFA model, the contributions of the steric and electrostatic fields are 68.10% and 31.90%, respectively, suggesting that the steric effect and electrical distribution of the groups will affect CI of QAs. In the steric field, the green area indicates that the introduction of bigger molecular groups in this area can improve the CI of QAs, while the yellow area indicates that the introduction of bigger molecular groups in this area can reduce the comprehensive effect of QAs. In the electrostatic field, the blue area indicates that the addition of positive groups is beneficial to improve the CI of QAs, and the red area indicates that the addition of negative groups is beneficial to the comprehensive effect of QAs.

This study uses marbofloxacin and levofloxacin as examples to modify the substituents at positions 1 (CH~3~) and 2 (CH~3~), respectively. From the contour maps of marbofloxacin, it can be seen that the area near the 1-position substituent is mainly blue, indicating that the introduction of a positive group at the 1-position substituent is beneficial to improve the QAs' CI; the green and red regions near the substituent at position 2 indicate that the introduction of bigger molecular groups and negative groups at the substituent in this position is conducive to improving the comprehensive effect value of the infrared and ultraviolet spectra of QAs. From the contour maps of levofloxacin, it can be seen that the vicinity of the substituent at position 1 is mainly blue, indicating that the introduction of a positively charged group at the substituent in this position is beneficial to improve the CI of QAs. The regions near the 2-position substituent are mainly green and red, indicating that the introduction of bigger molecular groups and negative groups at the 2-position substituent is conducive to improving the CI of QAs ([Figure 2](#ijerph-17-03239-f002){ref-type="fig"}).

In summary, the 1- and 2-position substituents of marbofloxacin and levofloxacin were modified, respectively. Among them, positive groups (-H, -SiH~3~, -C~2~H~5~, -PH~2~, -C~3~H~7~, -C~4~H~9~, -C~5~H~11~) can be introduced at the 1-position substituent of marbofloxacin, and bigger molecular groups and negative groups (-CH~2~F, -C~2~H~3~, -C~2~H, -CH~2~OH, -NH~2~, -NO, -NO~2~, -CHO, -COOH) can be introduced at the 2-position substituent. A total of 13 single-substituted marbofloxacin derivatives and 57 double-substituted marbofloxacin derivatives. Positive groups (-H, -SiH~3~, -C~2~H~5~, -C~3~H~7~, -C~4~H~9~, -C~5~H~11~) can be introduced at the 1-position substituent of levofloxacin, and bigger molecular groups and negative charged group (-C~2~H~3~, -NO, -NO~2~, -OCH~3~, -OH, -CN) can be introduced at the 2-position substituent. A total of four single-substituted levofloxacin derivatives and 13 double-substituted levofloxacin derivatives. Thus, a total of 87 QA derivatives were generated. The molecular structures of these derivatives are shown in [Table S1](#app1-ijerph-17-03239){ref-type="app"}.

3.5. Evaluation of Molecular Spectral Characteristics, Functional Characteristics, Environmental Friendliness, and Stability of the QA Derivatives {#sec3dot5-ijerph-17-03239}
--------------------------------------------------------------------------------------------------------------------------------------------------

### 3.5.1. Molecular Spectral Characteristics {#sec3dot5dot1-ijerph-17-03239}

In this paper, the 3D-QSAR model was used to evaluate the CI of 87 QA derivatives. In addition, a single-effect model of infrared spectrum and ultraviolet spectrum was established in order to further verify the feasibility and rationality of the fuzzy matter-element method. Therefore, the single-effect model was used to evaluate the infrared spectrum intensity and ultraviolet spectrum single-effect of 87 QA derivatives ([Table 6](#ijerph-17-03239-t006){ref-type="table"}).

By analyzing the data in [Table 6](#ijerph-17-03239-t006){ref-type="table"}, it can be seen that when the comprehensive effects of 87 QA derivatives were enhanced, the single effects of the IRI and UVI were also enhanced. The average value of the comprehensive effect enhancement range was 186.46%, the average value of the single-effect enhancement amplitude of the infrared spectrum was 69.45%, and the average value of the single-effect enhancement amplitude of the ultraviolet spectrum was 1398.39%. [Figure S1](#app1-ijerph-17-03239){ref-type="app"} was further generated to reflect the relationship between each QA structure and the associated activities (i.e., IRI, UVI, and CI) with marbofloxacin and levofloxacin used as the target molecules. Results indicated that the molecular design of QA derivatives showed positive effect on all activities with obvious enhancement of IRI, UVI, and CI values.

### 3.5.2. The Enhancement of CI, IRI, and UVI of QA Derivatives' {#sec3dot5dot2-ijerph-17-03239}

#### The Quantitative Mechanism Analysis of the Spectral Enhancement of QA Derivatives Based on the Contour Map

The contour map is used as the basis for obtaining accurate modification information in the 3D-QSAR model. Its spatial distribution and the size of each colored region are closely related to the activity of the designed derivative molecule. Therefore, this paper used marbofloxacin's position 2 as an example to compare the combined effect model of the infrared and ultraviolet spectra with the contour map of the single-effect model. A qualitative mechanism analysis of the spectral enhancement of QA derivatives was conducted in order to reveal the effect of the modified information presented in the contour map on the degree of spectral enhancement of the derivative molecule ([Figure 3](#ijerph-17-03239-f003){ref-type="fig"}).

According to the contour map of the steric field in the comprehensive effect model, the substituent at position 2 is surrounded by a green region, however, the other positions are also surrounded by green regions. Therefore, it can be considered that the steric field is not significant to the contribution of the 2-position substituent. In the infrared-effect model, there is no colored area near the 2-position substituent, thus, the steric field can be considered to have no contribution to the 2-position substituent in the model. In the ultraviolet-effect model, the green region is near the 2-position substituent, and it is the only green region distribution in the contour map. Therefore, the steric field is considered to have the most significant contribution to the 2-position substitution in the model. According to this, it can be qualitatively considered that the order of the contribution rate of the steric field to the modified position is UVI \> CI \> IRI.

According to the contour map of the steric field, the red area is distributed near the 2-position substituent; however, because the other positions are also close to red areas, the electrostatic field can be considered not significant to the contribution of the 2-position substituent. In the infrared-effect model, there is no colored area near the 2-position substituent, thus, the electrostatic field can be considered to have no contribution to the 2-position substituent in the model; in the ultraviolet-effect model, the red region is near the 2-position substituent, and it is the only red region distribution in the contour map. Therefore, the electrostatic field is considered to have the most significant contribution to the 2-position substitution in the ultraviolet-effect model. According to this, it can be qualitatively considered that the order of the contribution rate of the electrostatic field to the modified position is the UV single effect model \> combined effect model \> infrared single effect model.

In summary, according to the modified information provided by the contour map, it can be seen that the order of the contribution rate of the steric and electrostatic fields in the three groups of models are the UV single factor model \> combined effect model \> infrared single effect model. The results are consistent with spectral enhancement (the average value of the combined effect enhancement amplitude is 186.46%, the average value of the infrared spectrum single effect enhancement amplitude is 69.45%, and the ultraviolet spectrum single effect enhancement amplitude is 1398.39%). This shows that the spectral enhancement amplitude of QA derivatives has a certain internal relationship with the contribution of steric and electrostatic fields to its modified positions. The larger the contribution rate, the larger the corresponding spectral enhancement amplitude.

#### The Quantitative Mechanism Analysis of the Spectral Enhancement of QA Derivatives Based on the Modified Positions and the Properties of Substituted Groups

In addition to the distribution of colored regions in the contour map, the spectral enhancement amplitude is also affected by the properties of modified positions and the properties of substituted groups. Therefore, the number of modified positions, modified substitutes, and the properties of substituted groups were studied in this paper in order to reveal its intrinsic relationship with the spectral enhancement amplitude ([Table 7](#ijerph-17-03239-t007){ref-type="table"}).

According to the analysis of the data in [Table 7](#ijerph-17-03239-t007){ref-type="table"}, it was found that among the single substitution modification features, seven QA derivatives modified at the 1-position, such as Derivative 1, have an average enhancement range of the CI of 72.06%. The effect enhancement range is 60.02%, and the UV spectrum single effect enhancement range is 339.31%. Derivative 7 and the other 10 QA derivatives modified at the 2-position substituent have an average enhancement range of 113.08%. The single-effect enhancement of the infrared spectrum is 50.80%, and the single-effect enhancement of the ultraviolet spectrum is 421.09%. In the double-substitution modification feature, 70 QA derivatives, such as Derivative 14, are simultaneously modified at the 1- and 2-positions. The average enhancement of the CI is 208.39%, the IRI is 73.05%, and UVI is 1643.92%. From the results, it can be observed that under each substitution feature, the magnitude of the spectral enhancement amplitude in the three groups of models is still the UV single effect model \> composite effect model \> infrared single effect model, and the results are similar to the size distribution of the color regions in the contour map consistency.

In the comprehensive effect model, the spectral enhancement of QA derivatives obtained by modification at the 1-position, 2-position, and double substitution at 1- and 2-positions were 72.06%, 113.08%, and 208.39%, respectively. In the infrared single-effect model, the spectral enhancement of QA derivatives obtained by modification at the 1-position, 2-position, and double substitution at 1- and 2-positions were 60.02%, 50.80%, and 73.05%, respectively. In the effect model, the spectral enhancement of the QA derivatives obtained by modification at the 1-position, 2-position, and double substitution at 1- and 2-positions were 339.31%, 421.09%, and 1643.92%, respectively. By comparison, it can be found that, with the exception of the infrared single-effect model, the magnitudes of the spectral enhancement amplitudes in the remaining two models are both double-substitution features \> 2-position substituent single-substitution features \> 1-position substituent single-substitution features. In addition, the nature of the modified group selected for the 1-position substituent increased by 2.92%, the 2-position substituent was 61.93%, and the 1- and 2-position substituents were modified at the same time to 79.43%. The spectral enhancement amplitude has universal consistency, which indicates that the spectral enhancement amplitude of QA derivatives has a certain correlation with the properties of modification sites and groups. As the number of modification sites increases, the nature of the modified molecular groups becomes more prominent, and the spectrum will have a greater magnitude of enhancement.

### 3.5.3. Molecular Stability Evaluation of QA Derivatives {#sec3dot5dot3-ijerph-17-03239}

The 87 QA derivatives designed based on the CoMFA model are used to characterize the stability of 87 QA derivatives in order to further derivatize QAs.

The positive frequency value of the molecule can directly reflect whether the molecule can stably exist in the environment. When the positive frequency value is greater than zero, it indicates that the molecule can exist stably in the environment; otherwise, it cannot \[[@B24-ijerph-17-03239],[@B53-ijerph-17-03239]\]. In this paper, DFT was used to calculate the positive frequency values of 87 QAs derivatives to verify their stability ([Table 8](#ijerph-17-03239-t008){ref-type="table"}).

From the above results, the positive frequency values of the 87 QA derivatives are all greater than zero, indicating that all 87 QA derivatives designed in this study can stably exist in the environment.

### 3.5.4. Functional and Environmental Friendliness Evaluation of QA derivatives {#sec3dot5dot4-ijerph-17-03239}

Zhao et al. \[[@B16-ijerph-17-03239],[@B17-ijerph-17-03239]\] selected -lgLOEC (LOEC is the lowest observed effective concentration) to construct a hologram quantitative structure--activity relationship (HQSAR) model of the QAs genetic toxicity. QSAR models were designed independently to predict the genotoxicity, bioaccumulation, and biodegradability of the 87 QA derivatives ([Table 9](#ijerph-17-03239-t009){ref-type="table"}).

Genotoxicity refers to how QAs can selectively inhibit two enzymes that play a role in DNA synthesis in bacteria. Topoisomerase II and IV are two enzymes which interfere with the replication, transcription, repair, and recombination of bacterial DNA. These interferences make it impossible for bacteria to pass down genetic information, which lead to the increase in genotoxicity of QAs, making them conducive to improving the medicinal effect of this class of drugs \[[@B54-ijerph-17-03239]\]. According to the prediction results of genotoxicity, compared with marbofloxacin and levofloxacin, the genetic toxicity of 87 QA derivatives increased to varying degrees, and the increase range was 0.24%--29.01%.

The n-octanol-water partition coefficient (*K~ow~*) is one of the most important property parameters for studying the environmental behavior of organic matter. This parameter can simulate the distribution behavior of organic matter in lipid and water, and characterize the bioaccumulative ability of organic matter in environmental media. Organic substances with log*K~ow~* greater than 5.0 are banned worldwide \[[@B55-ijerph-17-03239]\]. According to the bioaccumulation prediction results, compared to marbofloxacin and levofloxacin, the bioaccumulation of 49 QA-derived molecules has been reduced to varying degrees, with a decrease of 0.25% to 60.47%, and the remaining 38 QA-derived molecules increased. The bioaccumulation of the molecule has increased to varying degrees, but its log*K~ow~* value is much lower than 5.0, which is below the banned threshold. Therefore, the bioaccumulation of all 87 QA derivatives are considered to be within the acceptable range.

The biodegradability is expressed by the LibDock Score (LDS) of the oxidoreductase enzyme of *Phanerochaete chrysosporium* and the QAs in the aerobic process of urban sewage treatment plants. The value of the LDS can represent the biodegradability of QAs \[[@B45-ijerph-17-03239]\]. Based on the prediction of biodegradability, it can be seen that compared to marbofloxacin and levofloxacin, the biodegradability of 34 QA derivatives has increased to varying degrees, with an increase of 0.12%--2.52%; for the remaining 53 QA derivatives, the biodegradability of biomolecules has decreased, with a decrease range of 0.12%--16.87%. Among them, the decline of nine QA derivatives is less than 1%, and their biodegradability can be considered unchanged. A total of 43 QA derivatives with increased or unchanged biodegradability can be selected.

In summary, among the 87 QA derivatives designed in this study, the properties of function (genetic toxicity) and environmentally friendliness (bioaccumulation, biodegradability) of 43 QAs are acceptable.

4. Conclusions {#sec4-ijerph-17-03239}
==============

Based on DFT and fuzzy matter-element method, the CI of 24 quinolone antibiotics (QAs) were calculated in this study. A 3D-QSAR model was then constructed by using CI as the dependent variable. A total of 87 QA derivatives with enhanced CI and single effects were designed. All of the designed QA derivatives can stably exist in the environment, and the functionality and environmental friendliness of 43 QA derivatives are within the acceptable range. Derivative 3 may be considered as an alternative of marbofloxacin with increased genotoxicity (10.83%) and biodegradability (0.47%), and decreased bioaccumulation (24.83%). Derivative 74 with the improved genotoxicity (17.49%) and biodegradability (0.29%), as well as the decreased bioaccumulation (6.58%), shows a better performance than levofloxacin. In addition, molecules combined with the modification information provided by the contour map were analyzed to identify why the CI of QA derivatives was enhanced. The research output provides theoretical support for obtaining novel antibiotic drug molecules that are easy to detect and less harmful to the environment and human health.

The following are available online at <https://www.mdpi.com/1660-4601/17/9/3239/s1>, Figure S1: Relationship between each QA structure and the associated activities (i.e., IRI, UVI and CI) with (a) marbofloxacin and (b) levofloxacin used as the target molecules, Table S1: Molecular structures of designed QA derivatives.
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Click here for additional data file.
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###### 

Infrared spectral intensity (IRI) and ultraviolet spectral intensity (UVI) of 24 quinolone antibiotics (QAs).

  No.           Name             IRI       UVI
  ------------- ---------------- --------- ---------
  Compound 1    Difloxacin       1924.76   2829.18
  Compound 2    Enrofloxacin     1289.58   4394.34
  Compound 3    Norfloxacin      1180.48   4627.19
  Compound 4    Lomefloxacin     1788.98   1950.61
  Compound 5    Ofloxacin        1428.91   3692.38
  Compound 6    Pefloxacin       1587.11   3542.25
  Compound 7    Fleroxacin       1882.42   1842.68
  Compound 8    Ciprofloxacin    1247.65   4045.59
  Compound 9    Balofloxacin     1368.19   3220.34
  Compound 10   Marbofloxacin    1265.41   264.82
  Compound 11   Pipemidic acid   2430.36   2563.72
  Compound 12   Cinoxacin        1631.51   9680.14
  Compound 13   Enoxacin         3427.59   8254.09
  Compound 14   Gatifloxacin     1363.79   2835.67
  Compound 15   Levofloxacin     1943.37   575.6
  Compound 16   Rufloxacin       1015.14   437.85
  Compound 17   Pazufloxacin     800.37    4259.61
  Compound 18   Nadifloxacin     1623.96   2878.37
  Compound 19   Sparfloxacin     1185.52   2542.11
  Compound 20   Sarafloxacin     1539.67   2605.82
  Compound 21   Besifloxacin     1682.72   3943.26
  Compound 22   Clinafloxacin    1571.06   4875.36
  Compound 23   Grepafloxacin    1489.4    2390.87
  Compound 24   Temafloxacin     2155.95   8643.35

ijerph-17-03239-t002_Table 2

###### 

The results of fuzzy membership, standard fuzzy matter-element and variance compound fuzzy matter-element matrix QAs.

  *M~i~*     *R'~mn~*   *R~Δ~*   Normalization                     
  ---------- ---------- -------- --------------- -------- -------- --------
  *M* ~1~    0.5615     0.2923   0.1922          0.5009   0.4280   0.2724
  *M* ~2~    0.3762     0.4540   0.3891          0.2982   0.1862   0.4386
  *M* ~3~    0.3444     0.4780   0.4298          0.2725   0.1447   0.4633
  *M* ~4~    0.5219     0.2015   0.2285          0.6376   0.3763   0.1790
  *M* ~5~    0.4169     0.3814   0.3400          0.3826   0.2392   0.3640
  *M* ~6~    0.4630     0.3659   0.2883          0.4020   0.2995   0.3481
  *M* ~7~    0.5492     0.1904   0.2032          0.6555   0.4119   0.1676
  *M* ~8~    0.3640     0.4179   0.4045          0.3388   0.1702   0.4016
  *M* ~9~    0.3992     0.3327   0.3610          0.4453   0.2161   0.3139
  *M* ~10~   0.3692     0.0274   0.3979          0.9460   0.1770   0.0000
  *M* ~11~   0.7091     0.2648   0.0846          0.5405   0.6204   0.2442
  *M* ~12~   0.4760     1.0000   0.2746          0.0000   0.3164   1.0000
  *M* ~13~   1.0000     0.8527   0.0000          0.0217   1.0000   0.8485
  *M* ~14~   0.3979     0.2929   0.3625          0.4999   0.2145   0.2730
  *M* ~15~   0.5670     0.0595   0.1875          0.8846   0.4351   0.0330
  *M* ~16~   0.2962     0.0452   0.4954          0.9116   0.0817   0.0184
  *M* ~17~   0.2335     0.4400   0.5875          0.3136   0.0000   0.4243
  *M* ~18~   0.4738     0.2973   0.2769          0.4937   0.3135   0.2776
  *M* ~19~   0.3459     0.2626   0.4279          0.5437   0.1466   0.2419
  *M* ~20~   0.4492     0.2692   0.3034          0.5341   0.2814   0.2486
  *M* ~21~   0.4909     0.4074   0.2591          0.3512   0.3358   0.3907
  *M* ~22~   0.4584     0.5036   0.2934          0.2464   0.2933   0.4897
  *M* ~23~   0.4345     0.2470   0.3198          0.5670   0.2623   0.2258
  *M* ~24~   0.6290     0.8929   0.1376          0.0115   0.5160   0.8899
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###### 

The results of objective weightings and comprehensive weightings of QAs' infrared and ultraviolet spectra.

  Entropy   Entropy Weights   Comprehensive Weights                     
  --------- ----------------- ----------------------- -------- -------- --------
  −0.9966   −0.9950           0.5002                  0.4998   0.5001   0.4999

From the results, it can be seen that the objective weights calculated by the entropy method are 0.5002 and 0.4998, and the comprehensive weights are 0.5001 and 0.4999, which are close to 0.5.

ijerph-17-03239-t004_Table 4

###### 

Calculation of comprehensive effects of infrared and ultraviolet spectra of 24 QAs based on fuzzy matter-element method.

  *e* ~i~   Comprehensive Effects   *e* ~i~    Comprehensive Effects   *e* ~i~    Comprehensive Effects
  --------- ----------------------- ---------- ----------------------- ---------- -----------------------
  *e* ~1~   0.4113                  *e* ~9~    0.3651                  *e* ~17~   0.3288
  *e* ~2~   0.4138                  *e* ~10~   0.1803                  *e* ~18~   0.3793
  *e* ~3~   0.4074                  *e* ~11~   0.4409                  *e* ~19~   0.3030
  *e* ~4~   0.3419                  *e* ~12~   0.6295                  *e* ~20~   0.3529
  *e* ~5~   0.3989                  *e* ~13~   0.8958                  *e* ~21~   0.4476
  *e* ~6~   0.4125                  *e* ~14~   0.3433                  *e* ~22~   0.4805
  *e* ~7~   0.3447                  *e* ~15~   0.2678                  *e* ~23~   0.3341
  *e* ~8~   0.3904                  *e* ~16~   0.1613                  *e* ~24~   0.7269
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###### 

The predicted combined effects of infrared and ultraviolet spectra (CI) of QAs using Comparative Molecular Field Analysis (CoMFA) model.

  No.                 Calculated Value   Predicted Value   Relative Deviation
  ------------------- ------------------ ----------------- --------------------
  ^a^ Compound 3      0.4074             0.3990            2.06%
  ^a^ Compound 4      0.3419             0.3540            −3.54%
  ^b^ Compound 7      0.3447             0.3970            −15.17%
  ^a^ Compound 8      0.3904             0.4170            −6.81%
  ^a^ Compound 9      0.3651             0.3620            0.85%
  ^a^ Compound 10     0.1803             0.1630            9.60%
  ^a^ Compound 11     0.4409             0.4430            −0.48%
  ^a^ Compound 12     0.6295             0.6520            −3.57%
  ^a^ Compound 15     0.2678             0.2680            −0.07%
  ^a^ Compound 16     0.1613             0.1950            −20.89%
  ^b^ Compound 18     0.3793             0.3800            −0.18%
  ^b^ Compound 20     0.3529             0.3770            −6.83%
  ^a^ Compound 21     0.4476             0.4300            3.93%
  ^a^ Compound 22     0.4805             0.4390            8.64%
  ^a^ Compound 23     0.3341             0.3290            1.53%
  ^a,b^ Compound 24   0.7269             0.7240            0.40%

^a^ Training set; ^b^ Test set.
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###### 

The predicted evaluation of 87 QA derivatives' molecular spectral characteristic.

  ----------------------------------------------------------------------------------------------------------------------------------------
  QA Derivatives   Position of\   CI         Relative Deviation   IRI       Relative Deviation   UVI       Relative Deviation   
                   Substitution                                                                                                 
  ---------------- -------------- ---------- -------------------- --------- -------------------- --------- -------------------- ----------
  Marbofloxacin    CH~3~          CH~3~      0.1803                         1265.4100                      264.8200             

  Derivative 1     SiH~3~         \-         0.2820               56.41%    2046.4446            61.72%    920.4496             247.58%

  Derivative 2     C~2~H~5~       \-         0.2690               49.20%    2128.1390            68.18%    749.8942             183.17%

  Derivative 3     PH~2~          \-         0.2850               58.07%    2051.1622            62.09%    916.2205             245.98%

  Derivative 4     C~3~H~7~       \-         0.2690               49.20%    2113.4890            67.02%    711.2135             168.56%

  Derivative 5     C~4~H~9~       \-         0.2690               49.20%    2133.0449            68.57%    714.4963             169.80%

  Derivative 6     C~5~H~11~      \-         0.2690               49.20%    2133.0449            68.57%    712.8530             169.18%

  Derivative 7     \-             CH~2~F     0.3510               94.68%    2051.1622            62.09%    1492.7944            463.70%

  Derivative 8     \-             C~2~H~3~   0.3210               78.04%    2023.0192            59.87%    1205.0359            355.04%

  Derivative 9     \-             C~2~H      0.3100               71.94%    1976.9696            56.23%    805.3784             204.12%

  Derivative 10    \-             CH~2~OH    0.2930               62.51%    2013.7242            59.14%    972.7472             267.32%

  Derivative 11    \-             NH~2~      0.3030               68.05%    2051.1622            62.09%    629.5062             137.71%

  Derivative 12    \-             NO         0.3530               95.78%    2009.0928            58.77%    1061.6956            300.91%

  Derivative 13    \-             NO~2~      0.3590               99.11%    1995.2623            57.68%    1142.8783            331.57%

  Derivative 14    SiH~3~         CH~2~F     0.3550               96.89%    2060.6299            62.84%    1442.1154            444.56%

  Derivative 15    PH~2~          CH~2~F     0.3510               94.68%    2046.4446            61.72%    1492.7944            463.70%

  Derivative 16    C~3~H~7~       CH~2~F     0.8050               346.48%   2511.8864            98.50%    8729.7137            3196.47%

  Derivative 17    C~4~H~9~       CH~2~F     0.8060               347.03%   2511.8864            98.50%    8729.7137            3196.47%

  Derivative 18    C~5~H~11~      CH~2~F     0.8060               347.03%   2511.8864            98.50%    8729.7137            3196.47%

  Derivative 19    H              C~2~H~3~   0.8150               352.02%   2624.2185            107.38%   9571.9407            3514.51%

  Derivative 20    SiH~3~         C~2~H~3~   0.8210               355.35%   2630.2680            107.86%   9354.0567            3432.23%

  Derivative 21    C~2~H~5~       C~2~H~3~   0.8190               354.24%   2630.2680            107.86%   9332.5430            3424.11%

  Derivative 22    PH~2~          C~2~H~3~   0.8180               353.69%   2630.2680            107.86%   9506.0479            3489.63%

  Derivative 23    C~3~H~7~       C~2~H~3~   0.8210               355.35%   2636.3314            108.34%   8356.0302            3055.36%

  Derivative 24    C~4~H~9~       C~2~H~3~   0.8210               355.35%   2636.3314            108.34%   8298.5077            3033.64%

  Derivative 25    C~5~H~11~      C~2~H~3~   0.8210               355.35%   2654.6056            109.78%   7870.4579            2872.00%

  Derivative 26    H              C~2~H      0.8160               352.58%   2570.3958            103.13%   9549.9259            3506.20%

  Derivative 27    SiH~3~         C~2~H      0.8210               355.35%   2594.1794            105.01%   9141.1324            3351.83%

  Derivative 28    C~2~H~5~       C~2~H      0.8210               355.35%   2612.1614            106.43%   8974.2879            3288.83%

  Derivative 29    PH~2~          C~2~H      0.8170               353.13%   2588.2129            104.54%   9484.1846            3481.37%

  Derivative 30    C~3~H~7~       C~2~H      0.7960               341.49%   2588.2129            104.54%   6180.1640            2233.72%

  Derivative 31    C~4~H~9~       C~2~H      0.7960               341.49%   2588.2129            104.54%   5807.6442            2093.05%

  Derivative 32    C~5~H~11~      C~2~H      0.7950               340.93%   2588.2129            104.54%   5754.3994            2072.95%

  Derivative 33    H              CH~2~OH    0.8200               354.80%   2523.4808            99.42%    9660.5088            3547.95%

  Derivative 34    SiH~3~         CH~2~OH    0.8260               358.13%   2535.1286            100.34%   9397.2331            3448.54%

  Derivative 35    C~2~H~5~       CH~2~OH    0.8250               357.57%   2535.1286            100.34%   8749.8378            3204.07%

  Derivative 36    PH~2~          CH~2~OH    0.8220               355.91%   2529.2980            99.88%    9616.1228            3531.19%

  Derivative 37    C~3~H~7~       CH~2~OH    0.8230               356.46%   2523.4808            99.42%    8933.0548            3273.26%

  Derivative 38    C~4~H~9~       CH~2~OH    0.8230               356.46%   2529.2980            99.88%    8974.2879            3288.83%

  Derivative 39    C~5~H~11~      CH~2~OH    0.8230               356.46%   2529.2980            99.88%    8974.2879            3288.83%

  Derivative 40    H              NH~2~      0.7920               339.27%   2546.8303            101.27%   8609.9375            3151.24%

  Derivative 41    SiH~3~         NH~2~      0.8000               343.70%   2558.5859            102.19%   8317.6377            3040.86%

  Derivative 42    C~2~H~5~       NH~2~      0.8020               344.81%   2582.2602            104.07%   8336.8118            3048.11%

  Derivative 43    PH~2~          NH~2~      0.8010               344.26%   2582.2602            104.07%   8336.8118            3048.11%

  Derivative 44    C~3~H~7~       NH~2~      0.7720               328.18%   2594.1794            105.01%   6123.5039            2212.33%

  Derivative 45    C~4~H~9~       NH~2~      0.3450               91.35%    2162.7185            70.91%    2805.4336            959.37%

  Derivative 46    C~5~H~11~      NH~2~      0.3730               106.88%   2187.7616            72.89%    2792.5438            954.51%

  Derivative 47    H              NO         0.3200               77.48%    2137.9621            68.95%    1606.9413            506.81%

  Derivative 48    SiH~3~         NO         0.2730               51.41%    2192.8049            73.29%    1166.8096            340.60%

  Derivative 49    C~2~H~5~       NO         0.2420               34.22%    2157.7444            70.52%    984.0111             271.58%

  Derivative 50    PH~2~          NO         0.4150               130.17%   1972.4227            55.87%    2074.9135            683.52%

  Derivative 51    C~3~H~7~       NO         0.2440               35.33%    2128.1390            68.18%    990.8319             274.15%

  Derivative 52    C~4~H~9~       NO         0.2460               36.44%    2137.9621            68.95%    933.2543             252.41%

  Derivative 53    C~5~H~11~      NO         0.2460               36.44%    2128.1390            68.18%    937.5620             254.04%

  Derivative 54    H              NO~2~      0.3170               75.82%    2079.6967            64.35%    1534.6170            479.49%

  Derivative 55    SiH~3~         NO~2~      0.2530               40.32%    2113.4890            67.02%    1156.1122            336.57%

  Derivative 56    C~2~H~5~       NO~2~      0.2340               29.78%    2094.1125            65.49%    1324.3415            400.09%

  Derivative 57    C~3~H~7~       NO~2~      0.2350               30.34%    2074.9135            63.97%    918.3326             246.78%

  Derivative 58    C~4~H~9~       NO~2~      0.2360               30.89%    2089.2961            65.11%    889.2011             235.78%

  Derivative 59    C~5~H~11~      NO~2~      0.2360               30.89%    2089.2961            65.11%    870.9636             228.89%

  Derivative 60    H              CHO        0.4500               149.58%   1981.5270            56.59%    3019.9517            1040.38%

  Derivative 61    SiH~3~         CHO        0.4110               127.95%   1896.7059            49.89%    2488.8573            839.83%

  Derivative 62    C~2~H~5~       CHO        0.3270               81.36%    1909.8533            50.93%    1753.8805            562.29%

  Derivative 63    C~3~H~7~       CHO        0.3130               73.60%    1918.6687            51.62%    1774.1895            569.96%

  Derivative 64    C~4~H~9~       CHO        0.3260               80.81%    1927.5249            52.32%    2032.3570            667.45%

  Derivative 65    C~5~H~11~      CHO        0.3270               81.36%    1923.0917            51.97%    2018.3664            662.17%

  Derivative 66    H              COOH       0.4550               152.36%   2065.3802            63.22%    2951.2092            1014.42%

  Derivative 67    SiH~3~         COOH       0.3960               119.63%   2074.9135            63.97%    2301.4418            769.06%

  Derivative 68    C~2~H~5~       COOH       0.3170               75.82%    1995.2623            57.68%    1923.0917            626.19%

  Derivative 69    C~3~H~7~       COOH       0.3030               68.05%    1986.0949            56.95%    1905.4607            619.53%

  Derivative 70    C~4~H~9~       COOH       0.3130               73.60%    1986.0949            56.95%    2108.6281            696.25%

  Levofloxacin     CH~3~          CH~3~      0.2678                         1943.3700                      575.6000             

  Derivative 71    C~4~H~9~                  0.7850               193.13%   2409.9054            24.01%    7430.1914            1190.86%

  Derivative 72    C~4~H~9~       C~2~H~3~   0.7500               180.06%   2636.3314            35.66%    5834.4510            913.63%

  Derivative 73    C~3~H~7~       OH         0.7430               177.45%   2552.7013            31.35%    2108.6281            266.34%

  Derivative 74    C~3~H~7~       OH         0.6690               149.81%   2328.0913            19.80%    1741.8069            202.61%

  Derivative 75    H              OH         0.7210               169.23%   2404.3628            23.72%    3881.5037            574.34%

  Derivative 76                   OCH~3~     0.7670               186.41%   2488.8573            28.07%    7328.2453            1173.15%

  Derivative 77    C~2~H~5~       OCH~3~     0.7420               177.07%   2624.2185            35.03%    5296.6344            820.19%

  Derivative 78    SiH~3~         OCH~3~     0.7560               182.30%   2529.2980            30.15%    7533.5556            1208.82%

  Derivative 79    C~5~H~11~      OCH~3~     0.7560               182.30%   2477.4221            27.48%    1496.2357            159.94%

  Derivative 80    C~3~H~7~       CN         0.7550               181.93%   2618.1830            34.72%    6095.3690            958.96%

  Derivative 81    SiH~3~         NO         0.7560               182.30%   2275.0974            17.07%    3169.5675            450.65%

  Derivative 82                   NO~2~      0.7530               181.18%   2642.4088            35.97%    5035.0061            774.74%

  Derivative 83    C~2~H~5~       NO~2~      0.7590               183.42%   2466.0393            26.89%    5223.9619            807.57%

  Derivative 84    SiH~3~         NO~2~      0.7680               186.78%   2387.8113            22.87%    7177.9429            1147.04%

  Derivative 85    C~3~H~7~       NO~2~      0.7530               181.18%   2506.1093            28.96%    5105.0500            786.91%

  Derivative 86    C~4~H~9~       NO~2~      0.7540               181.55%   2588.2129            33.18%    5495.4087            854.73%

  Derivative 87                   CHO        0.7850               193.13%   2488.8573            28.07%    1741.8069            202.61%
  ----------------------------------------------------------------------------------------------------------------------------------------
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###### 

The modified positions and properties of 87 QAs Derivatives.

  Molecular Substitution Type   QA Derivatives                            Modified Positions and Properties of Substituted Groups                                 
  ----------------------------- ---------------- ------- ------- -------- --------------------------------------------------------- --------- --------- --------- --------
  Monosubstitution              Derivative 1     2.120   9.05%   \-       \-                                                        \-        \-        \-        \-
  Derivative 2                  2.315            0.69%   \-      \-       \-                                                        \-        \-        \-        
  Derivative 3                  2.154            7.59%   \-      \-       \-                                                        \-        \-        \-        
  Derivative 4                  2.314            0.73%   \-      \-       \-                                                        \-        \-        \-        
  Derivative 5                  2.313            0.77%   \-      \-       \-                                                        \-        \-        \-        
  Derivative 6                  2.312            0.82%   \-      \-       \-                                                        \-        \-        \-        
  Derivative 71                 2.313            0.77%   \-      \-       \-                                                        \-        \-        \-        
  Derivative 7                  \-               \-      2.644   13.43%   33                                                        120.00%   66.71%    \-        
  Derivative 8                  \-               \-      2.358   1.16%    27                                                        80.00%    40.58%    \-        
  Derivative 9                  \-               \-      2.530   8.54%    25                                                        66.67%    37.60%    \-        
  Derivative 10                 \-               \-      2.491   6.86%    31                                                        106.67%   56.77%    \-        
  Derivative 11                 \-               \-      2.437   4.55%    16                                                        6.67%     5.61%     \-        
  Derivative 12                 \-               \-      2.920   25.27%   30                                                        100.00%   62.63%    \-        
  Derivative 13                 \-               \-      3.104   33.16%   46                                                        206.67%   119.91%   \-        
  Derivative 76                 \-               \-      2.460   5.53%    31                                                        106.67%   56.10%    \-        
  Derivative 82                 \-               \-      3.104   33.16%   46                                                        206.67%   119.91%   \-        
  Derivative 87                 \-               \-      2.647   13.56%   29                                                        93.33%    53.44%    \-        
  Disubstituted                 Derivative 14    2.120   9.05%   2.644    13.43%                                                    33        120.00%   85.90%    94.95%
  Derivative 15                 2.154            7.59%   2.644   13.43%   33                                                        120.00%   85.90%    93.49%    
  Derivative 16                 2.314            0.73%   2.644   13.43%   33                                                        120.00%   85.90%    86.63%    
  Derivative 17                 2.313            0.77%   2.644   13.43%   33                                                        120.00%   85.90%    86.67%    
  Derivative 18                 2.312            0.82%   2.644   13.43%   33                                                        120.00%   85.90%    86.71%    
  Derivative 19                 2.200            5.62%   2.358   1.16%    27                                                        80.00%    54.77%    60.39%    
  Derivative 20                 2.120            9.05%   2.358   1.16%    27                                                        80.00%    54.77%    63.82%    
  Derivative 21                 2.315            0.69%   2.358   1.16%    27                                                        80.00%    54.77%    55.46%    
  Derivative 22                 2.154            7.59%   2.358   1.16%    27                                                        80.00%    54.77%    62.36%    
  Derivative 23                 2.314            0.73%   2.358   1.16%    27                                                        80.00%    54.77%    55.50%    
  Derivative 24                 2.313            0.77%   2.358   1.16%    27                                                        80.00%    54.77%    55.54%    
  Derivative 25                 2.312            0.82%   2.358   1.16%    27                                                        80.00%    54.77%    55.59%    
  Derivative 26                 2.200            5.62%   2.530   8.54%    25                                                        66.67%    48.07%    53.69%    
  Derivative 27                 2.120            9.05%   2.530   8.54%    25                                                        66.67%    48.07%    57.12%    
  Derivative 28                 2.315            0.69%   2.530   8.54%    25                                                        66.67%    48.07%    48.75%    
  Derivative 29                 2.154            7.59%   2.530   8.54%    25                                                        66.67%    48.07%    55.66%    
  Derivative 30                 2.314            0.73%   2.530   8.54%    25                                                        66.67%    48.07%    48.79%    
  Derivative 31                 2.313            0.77%   2.530   8.54%    25                                                        66.67%    48.07%    48.84%    
  Derivative 32                 2.312            0.82%   2.530   8.54%    25                                                        66.67%    48.07%    48.88%    
  Derivative 33                 2.200            5.62%   2.491   6.86%    31                                                        106.67%   74.73%    80.35%    
  Derivative 34                 2.120            9.05%   2.491   6.86%    31                                                        106.67%   74.73%    83.78%    
  Derivative 35                 2.315            0.69%   2.491   6.86%    31                                                        106.67%   74.73%    75.42%    
  Derivative 36                 2.154            7.59%   2.491   6.86%    31                                                        106.67%   74.73%    82.32%    
  Derivative 37                 2.314            0.73%   2.491   6.86%    31                                                        106.67%   74.73%    75.46%    
  Derivative 38                 2.313            0.77%   2.491   6.86%    31                                                        106.67%   74.73%    75.50%    
  Derivative 39                 2.312            0.82%   2.491   6.86%    31                                                        106.67%   74.73%    75.54%    
  Derivative 40                 2.200            5.62%   2.437   4.55%    16                                                        6.67%     5.99%     11.61%    
  Derivative 41                 2.120            9.05%   2.437   4.55%    16                                                        6.67%     5.99%     15.04%    
  Derivative 42                 2.315            0.69%   2.437   4.55%    16                                                        6.67%     5.99%     6.67%     
  Derivative 43                 2.154            7.59%   2.437   4.55%    16                                                        6.67%     5.99%     13.58%    
  Derivative 44                 2.314            0.73%   2.437   4.55%    16                                                        6.67%     5.99%     6.72%     
  Derivative 45                 2.313            0.77%   2.437   4.55%    16                                                        6.67%     5.99%     6.76%     
  Derivative 46                 2.312            0.82%   2.437   4.55%    16                                                        6.67%     5.99%     6.80%     
  Derivative 47                 2.200            5.62%   2.920   25.27%   30                                                        100.00%   76.09%    81.71%    
  Derivative 48                 2.120            9.05%   2.920   25.27%   30                                                        100.00%   76.09%    85.14%    
  Derivative 49                 2.315            0.69%   2.920   25.27%   30                                                        100.00%   76.09%    76.77%    
  Derivative 50                 2.154            7.59%   2.920   25.27%   30                                                        100.00%   76.09%    83.68%    
  Derivative 51                 2.314            0.73%   2.920   25.27%   30                                                        100.00%   76.09%    76.82%    
  Derivative 52                 2.313            0.77%   2.920   25.27%   30                                                        100.00%   76.09%    76.86%    
  Derivative 53                 2.312            0.82%   2.920   25.27%   30                                                        100.00%   76.09%    76.90%    
  Derivative 54                 2.200            5.62%   3.104   33.16%   46                                                        206.67%   151.15%   156.76%   
  Derivative 55                 2.120            9.05%   3.104   33.16%   46                                                        206.67%   151.15%   160.20%   
  Derivative 56                 2.315            0.69%   3.104   33.16%   46                                                        206.67%   151.15%   151.83%   
  Derivative 57                 2.314            0.73%   3.104   33.16%   46                                                        206.67%   151.15%   151.87%   
  Derivative 58                 2.313            0.77%   3.104   33.16%   46                                                        206.67%   151.15%   151.92%   
  Derivative 59                 2.312            0.82%   3.104   33.16%   46                                                        206.67%   151.15%   151.96%   
  Derivative 60                 2.200            5.62%   2.647   13.56%   29                                                        93.33%    67.80%    73.42%    
  Derivative 61                 2.120            9.05%   2.647   13.56%   29                                                        93.33%    67.80%    76.86%    
  Derivative 62                 2.315            0.69%   2.647   13.56%   29                                                        93.33%    67.80%    68.49%    
  Derivative 63                 2.314            0.73%   2.647   13.56%   29                                                        93.33%    67.80%    68.53%    
  Derivative 64                 2.313            0.77%   2.647   13.56%   29                                                        93.33%    67.80%    68.58%    
  Derivative 65                 2.312            0.82%   2.647   13.56%   29                                                        93.33%    67.80%    68.62%    
  Derivative 66                 2.200            5.62%   2.769   18.79%   45                                                        200.00%   142.01%   147.63%   
  Derivative 67                 2.120            9.05%   2.769   18.79%   45                                                        200.00%   142.01%   151.06%   
  Derivative 68                 2.315            0.69%   2.769   18.79%   45                                                        200.00%   142.01%   142.70%   
  Derivative 69                 2.314            0.73%   2.769   18.79%   45                                                        200.00%   142.01%   142.74%   
  Derivative 70                 2.313            0.77%   2.769   18.79%   45                                                        200.00%   142.01%   142.79%   
  Derivative 72                 2.313            0.77%   2.358   1.16%    27                                                        80.00%    54.77%    55.54%    
  Derivative 73                 2.314            0.73%   2.585   10.90%   17                                                        13.33%    12.55%    13.28%    
  Derivative 74                 2.314            0.73%   2.585   10.90%   17                                                        13.33%    12.55%    13.28%    
  Derivative 75                 2.200            5.62%   2.585   10.90%   17                                                        13.33%    12.55%    18.17%    
  Derivative 77                 2.315            0.69%   2.460   5.53%    31                                                        106.67%   74.30%    74.99%    
  Derivative 78                 2.120            9.05%   2.460   5.53%    31                                                        106.67%   74.30%    83.36%    
  Derivative 79                 2.312            0.82%   2.460   5.53%    31                                                        106.67%   74.30%    75.12%    
  Derivative 80                 2.314            0.73%   2.792   19.78%   26                                                        73.33%    56.20%    56.92%    
  Derivative 81                 2.120            9.05%   2.920   25.27%   30                                                        100.00%   76.09%    85.14%    
  Derivative 83                 2.315            0.69%   3.104   33.16%   46                                                        206.67%   151.15%   151.83%   
  Derivative 84                 2.120            9.05%   3.104   33.16%   46                                                        206.67%   151.15%   160.20%   
  Derivative 85                 2.314            0.73%   3.104   33.16%   46                                                        206.67%   151.15%   151.87%   
  Derivative 86                 2.313            0.77%   3.104   33.16%   46                                                        206.67%   151.15%   151.92%   
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###### 

The results of positive frequency values of 87 QAs derivatives.

  QA Derivatives   Positive Frequency Value   QA Derivatives   Positive Frequency Value   QA Derivatives   Positive Frequency Value
  ---------------- -------------------------- ---------------- -------------------------- ---------------- --------------------------
  Derivative 1     20.78                      Derivative 30    14.97                      Derivative 59    10.15
  Derivative 2     17.07                      Derivative 31    14.85                      Derivative 60    28.78
  Derivative 3     19.93                      Derivative 32    12.63                      Derivative 61    18.22
  Derivative 4     15.47                      Derivative 33    24.17                      Derivative 62    25.68
  Derivative 5     14.17                      Derivative 34    17.19                      Derivative 63    23.33
  Derivative 6     13.15                      Derivative 35    18.39                      Derivative 64    21.80
  Derivative 7     25.16                      Derivative 36    19.52                      Derivative 65    18.79
  Derivative 8     21.84                      Derivative 37    19.74                      Derivative 66    28.44
  Derivative 9     22.60                      Derivative 38    14.32                      Derivative 67    23.12
  Derivative 10    20.75                      Derivative 39    13.44                      Derivative 68    24.75
  Derivative 11    21.58                      Derivative 40    31.02                      Derivative 69    22.49
  Derivative 12    24.54                      Derivative 41    20.39                      Derivative 70    20.99
  Derivative 13    22.29                      Derivative 42    17.77                      Derivative 71    15.37
  Derivative 14    20.67                      Derivative 43    20.83                      Derivative 72    11.09
  Derivative 15    20.88                      Derivative 44    20.82                      Derivative 73    15.30
  Derivative 16    18.33                      Derivative 45    15.87                      Derivative 74    16.74
  Derivative 17    17.08                      Derivative 46    12.92                      Derivative 75    28.59
  Derivative 18    14.97                      Derivative 47    24.63                      Derivative 76    21.50
  Derivative 19    21.27                      Derivative 48    19.56                      Derivative 77    16.28
  Derivative 20    16.15                      Derivative 49    21.39                      Derivative 78    19.62
  Derivative 21    19.96                      Derivative 50    14.89                      Derivative 79    9.36
  Derivative 22    18.43                      Derivative 51    13.37                      Derivative 80    18.66
  Derivative 23    16.27                      Derivative 52    12.78                      Derivative 81    16.26
  Derivative 24    15.53                      Derivative 53    7.10                       Derivative 82    21.73
  Derivative 25    14.51                      Derivative 54    23.28                      Derivative 83    20.00
  Derivative 26    24.80                      Derivative 55    20.02                      Derivative 84    21.43
  Derivative 27    18.49                      Derivative 56    17.86                      Derivative 85    18.49
  Derivative 28    21.60                      Derivative 57    13.65                      Derivative 86    11.53
  Derivative 29    20.14                      Derivative 58    12.72                      Derivative 87    23.13
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###### 

Predicted results of genotoxicity, bioaccumulation, and biodegradability of 87 QA derivatives.

  QA Derivatives   Genotoxicity   Relative Deviation   Bioaccumulation   Relative Deviation   Biodegradability   Relative Deviation
  ---------------- -------------- -------------------- ----------------- -------------------- ------------------ --------------------
  Marbofloxacin    8.4600                              1.1840                                 1.7050             
  Derivative 1     9.5390         12.75%               0.9650            −18.50%              1.7070             0.12%
  Derivative 2     9.8690         16.65%               1.1630            −1.77%               1.7250             1.17%
  Derivative 3     9.3760         10.83%               0.8900            −24.83%              1.7130             0.47%
  Derivative 4     9.6020         13.50%               1.1730            −0.93%               1.7240             1.11%
  Derivative 5     9.5320         12.67%               1.1740            −0.84%               1.7250             1.17%
  Derivative 6     9.6380         13.92%               1.1750            −0.76%               1.7240             1.11%
  Derivative 7     9.0310         6.75%                1.3610            14.95%               1.7190             0.82%
  Derivative 8     8.9180         5.41%                1.3730            15.96%               1.7290             1.41%
  Derivative 9     8.5310         0.84%                1.2810            8.19%                1.7170             0.70%
  Derivative 10    9.2950         9.87%                1.5920            34.46%               1.7030             −0.12%
  Derivative 11    9.8810         16.80%               1.1110            −6.17%               1.7130             0.47%
  Derivative 12    8.4810         0.25%                1.5260            28.89%               1.6900             −0.88%
  Derivative 13    9.0470         6.94%                1.2460            5.24%                1.7350             1.76%
  Derivative 14    9.6010         13.49%               1.1590            −2.11%               1.7160             0.65%
  Derivative 15    9.4670         11.90%               1.0520            −11.15%              1.7190             0.82%
  Derivative 16    9.8060         15.91%               0.6090            −48.56%              1.4940             −12.38%
  Derivative 17    9.7360         15.08%               0.6080            −48.65%              1.4940             −12.38%
  Derivative 18    9.8420         16.34%               0.6060            −48.82%              1.4940             −12.38%
  Derivative 19    9.2230         9.02%                0.5660            −52.20%              1.5050             −11.73%
  Derivative 20    9.4870         12.14%               0.5650            −52.28%              1.4990             −12.08%
  Derivative 21    9.9670         17.81%               0.5720            −51.69%              1.5000             −12.02%
  Derivative 22    9.4730         11.97%               0.5430            −54.14%              1.5040             −11.79%
  Derivative 23    9.7000         14.66%               0.5760            −51.35%              1.5070             −11.61%
  Derivative 24    9.6300         13.83%               0.5760            −51.35%              1.5060             −11.67%
  Derivative 25    9.7350         15.07%               0.5760            −51.35%              1.5100             −11.44%
  Derivative 26    8.8350         4.43%                0.5470            −53.80%              1.5260             −10.50%
  Derivative 27    8.9990         6.37%                0.5450            −53.97%              1.5230             −10.67%
  Derivative 28    9.5790         13.23%               0.5550            −53.13%              1.5290             −10.32%
  Derivative 29    9.0860         7.40%                0.5230            −55.83%              1.5220             −10.73%
  Derivative 30    9.3130         10.08%               0.5910            −50.08%              1.5270             −10.44%
  Derivative 31    9.2430         9.26%                0.5950            −49.75%              1.5290             −10.32%
  Derivative 32    9.3480         10.50%               0.5970            −49.58%              1.5300             −10.26%
  Derivative 33    9.6000         13.48%               0.5350            −54.81%              1.5060             −11.67%
  Derivative 34    9.7820         15.63%               0.5330            −54.98%              1.5010             −11.96%
  Derivative 35    10.3440        22.27%               0.5450            −53.97%              1.5030             −11.85%
  Derivative 36    9.8510         16.44%               0.5120            −56.76%              1.5020             −11.91%
  Derivative 37    10.0780        19.13%               0.5440            −54.05%              1.4980             −12.14%
  Derivative 38    10.0070        18.29%               0.5440            −54.05%              1.4990             −12.08%
  Derivative 39    10.1130        19.54%               0.5440            −54.05%              1.5010             −11.96%
  Derivative 40    10.1700        20.21%               0.5020            −57.60%              1.5130             −11.26%
  Derivative 41    10.1300        19.74%               0.4950            −58.19%              1.5120             −11.32%
  Derivative 42    10.9140        29.01%               0.5150            −56.50%              1.5090             −11.50%
  Derivative 43    10.4210        23.18%               0.4680            −60.47%              1.5150             −11.14%
  Derivative 44    10.6480        25.86%               0.5600            −52.70%              1.5180             −10.97%
  Derivative 45    10.5810        25.07%               1.1810            −0.25%               1.7350             1.76%
  Derivative 46    10.6870        26.32%               1.1840            0.00%                1.7340             1.70%
  Derivative 47    8.7900         3.90%                1.4680            23.99%               1.7140             0.53%
  Derivative 48    8.8820         4.99%                1.5270            28.97%               1.7120             0.41%
  Derivative 49    9.5340         12.70%               1.6600            40.20%               1.7140             0.53%
  Derivative 50    10.2130        20.72%               1.2030            1.60%                1.7480             2.52%
  Derivative 51    9.2680         9.55%                1.6710            41.13%               1.7140             0.53%
  Derivative 52    9.1970         8.71%                1.6780            41.72%               1.7150             0.59%
  Derivative 53    9.3030         9.96%                1.6730            41.30%               1.7150             0.59%
  Derivative 54    9.3480         10.50%               1.2920            9.12%                1.7150             0.59%
  Derivative 55    9.5060         12.36%               1.2600            6.42%                1.7170             0.70%
  Derivative 56    10.0920        19.29%               1.5080            27.36%               1.7190             0.82%
  Derivative 57    9.8260         16.15%               1.5030            26.94%               1.7150             0.59%
  Derivative 58    9.7550         15.31%               1.5080            27.36%               1.7150             0.59%
  Derivative 59    9.8610         16.56%               1.5100            27.53%               1.7160             0.65%
  Derivative 60    8.7220         3.10%                0.8730            −26.27%              1.6940             −0.65%
  Derivative 61    9.2850         9.75%                0.9190            −22.38%              1.6930             −0.70%
  Derivative 62    9.4710         11.95%               1.1430            −3.46%               1.7000             −0.29%
  Derivative 63    9.1970         8.71%                1.1680            −1.35%               1.7000             −0.29%
  Derivative 64    9.1270         7.88%                1.1810            −0.25%               1.7020             −0.18%
  Derivative 65    9.2330         9.14%                1.1870            0.25%                1.7000             −0.29%
  Derivative 66    8.8390         4.48%                1.2240            3.38%                1.7380             1.94%
  Derivative 67    9.4460         11.65%               1.2440            5.07%                1.7430             2.23%
  Derivative 68    9.5880         13.33%               1.5060            27.20%               1.7430             2.23%
  Derivative 69    9.3150         10.11%               1.5320            29.39%               1.7400             2.05%
  Derivative 70    9.2440         9.27%                1.5460            30.57%               1.7350             1.76%
  Levofloxacin     7.9750                              1.4590                                 1.7070             
  Derivative 71    8.9340         12.03%               1.5280            4.73%                1.4730             −13.71%
  Derivative 72    8.7350         9.53%                1.4300            −1.99%               1.4750             −13.59%
  Derivative 73    9.0150         13.04%               1.5230            4.39%                1.5320             −10.25%
  Derivative 74    9.3700         17.49%               1.3630            −6.58%               1.7120             0.29%
  Derivative 75    9.0220         13.13%               1.4800            1.44%                1.6800             −1.58%
  Derivative 76    8.4140         5.50%                1.5220            4.32%                1.4980             −12.24%
  Derivative 77    9.4620         18.65%               1.3840            −5.14%               1.4730             −13.71%
  Derivative 78    8.9870         12.69%               1.6650            14.12%               1.4560             −14.70%
  Derivative 79    9.0140         13.03%               1.2830            −12.06%              1.5410             −9.72%
  Derivative 80    8.7330         9.50%                1.5340            5.14%                1.5350             −10.08%
  Derivative 81    8.5510         7.22%                1.6340            11.99%               1.7030             −0.23%
  Derivative 82    8.1340         1.99%                1.5160            3.91%                1.4660             −14.12%
  Derivative 83    9.1820         15.13%               1.6460            12.82%               1.4190             −16.87%
  Derivative 84    8.4940         6.51%                1.5230            4.39%                1.4390             −15.70%
  Derivative 85    8.9160         11.80%               1.5790            8.22%                1.4700             −13.88%
  Derivative 86    8.8460         10.92%               1.5280            4.73%                1.4610             −14.41%
  Derivative 87    7.9940         0.24%                1.5970            9.46%                1.5430             −9.61%
